Stock Price
1.36
Daily Change
-0.04 -2.52%
Monthly
-16.36%
Yearly
3.44%
Q2 Forecast
1.38

Autolus Therapeutics Ltd reported $-90.33M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AstraZeneca USD 2.33B 207M Dec/2025
Autolus Therapeutics Ltd USD -90.33M 11.21M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Silence Therapeutics USD -11.77M 9.19M Dec/2025